Latest Posts

See what's new

Animas Customers: Medtronic is Here to Support You

Dear Animas Customers, Following the recent announcement that Animas will exit the market, we heard from many customers who are understandably anxious about what this means for them. Please know that we’re dedicated to supporting you through this transition and welcoming you to the Medtronic family. Our team is ready to support you and

Proving the Economic Benefits of Professional CGM

Our economic analysis of professional CGM using real-world data was published in the Journal of Medical Economics. With this analysis, Medtronic Diabetes is the first to demonstrate the significant clinical and health economic benefits of professional CGM products – such as iPro™2 – for people living with type 2 diabetes, and healthcare systems. Prior

Medtronic Diabetes Announces Outcomes-Driven Agreement in Bangladesh

I’m excited to announce a new patient-centric partnership which will expand access to our therapies to people living with diabetes in Asia Pacific (APAC). We are partnering with the world’s largest diabetes out-patient hospital – the Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM) – to drive positive health

Medtronic Announces New Outcomes-Based Agreement with Aetna

Today we announced an outcomes-based agreement with Aetna for type 1 and type 2 diabetes patients who currently receive multiple daily insulin injections for their diabetes management. The agreement will measure health outcomes for those patients that choose to transition to pump therapy using a Medtronic insulin pump featuring SmartGuard™ Technology – the only

MiniMed 670G System Launches in the United States

I am pleased to share that today we announced the commercial launch of the MiniMed 670G system. Since earlier- than-expected FDA approval in September 2016, we have been working to ensure payer coverage, market and manufacturing readiness, as well as appropriate training of employees, clinicians, educators and patients on the new system. We also

First Canadian Customer of Diabetes Self-Management Program with Canary Health

I’m happy to announce that in partnership with Canary Health, a leading provider of proven digital health self-management programs for people with chronic disease, we have started our first project in Canada. Bruyère Continuing Care, Ontario’s largest provider of sub-acute care, will offer its patients with type 2 diabetes the newly updated online version
Life with MiniMed 670G System: Perspective of a Busy Teenager

Life with MiniMed 670G System: Perspective of a Busy Teenager

When fifteen-year-old Nikhita wakes up knowing her glucose is stable and will stay in range, she owns the day. Diagnosed with type 1 diabetes at the age of five, the MiniMed 670G system has given Nikhita increased confidence, and reinforced her motivation and determination to continue to achieve more. I started using the MiniMed
Thriving on Life with the MiniMed 670G System

Thriving on Life with the MiniMed 670G System

For the past 30 years, John Caldwell felt like managing his type 1 diabetes was a full-time job. Now with the MiniMed 670G system, John worries less about managing his diabetes and spends more time doing the things he enjoys – extreme sports, such as skydiving, biking, snowboarding, hiking, and backpacking. John is one
Diabeter Wins Value-Based Healthcare Prize 2017

Diabeter Wins Value-Based Healthcare Prize 2017

On May 11, 2017, the Value-Based Healthcare Center Europe awarded Diabeter with the Value-Based Healthcare Prize 2017. I am so proud of the work by the Diabeter team, and am not surprised that their hard work and innovative approach is being recognized. The Value-Based Healthcare Prize rewards projects that have adopted a fundamentally new
Hooman Hakami Talks Women in Leadership at Medtronic

Hooman Hakami Talks Women in Leadership at Medtronic

Earlier this year, the Medtronic Women’s Network (MWN), the company’s oldest and largest employee resource group (ERG), announced the appointment of Hooman Hakami as its new executive sponsor. Hooman has been the executive vice president and group president of the Diabetes Group at Medtronic since June 2014. He provides overall strategic direction and operational